{"id":"compound-danshen-dripping-pills","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding or bruising"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This traditional Chinese medicine-derived formulation contains active compounds from Salvia miltiorrhiza (danshen) that act as antiplatelet and anticoagulant agents. The mechanism involves enhancement of microcirculation, reduction of blood viscosity, and prevention of thrombotic events, thereby improving tissue perfusion and oxygen delivery to ischemic areas.","oneSentence":"Compound danshen dripping pills improve blood circulation and reduce blood stasis by promoting vasodilation and inhibiting platelet aggregation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:30:56.933Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"},{"name":"Myocardial infarction prevention"},{"name":"Coronary artery disease"}]},"trialDetails":[{"nctId":"NCT07041359","phase":"PHASE4","title":"Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-08-18","conditions":"Coronary Arterial Disease (CAD)","enrollment":120},{"nctId":"NCT06727890","phase":"PHASE4","title":"Compound Danshen Dripping Pill for Diabetic Microvascular Angina","status":"NOT_YET_RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2025-01-01","conditions":"Diabetic Microvascular Angina","enrollment":162},{"nctId":"NCT06092736","phase":"PHASE4","title":"Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2018-12-18","conditions":"Microvascular Angina","enrollment":100},{"nctId":"NCT05295329","phase":"NA","title":"Effect of Compound Danshen Dripping Pills on Diabetic Patients With Coronary Microcirculation Disturbance","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2022-04-01","conditions":"Diabetes","enrollment":120},{"nctId":"NCT03270787","phase":"PHASE1, PHASE2","title":"Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2016-06-24","conditions":"Acute Mountain Sickness","enrollment":58},{"nctId":"NCT02388984","phase":"PHASE3","title":"Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2013-05","conditions":"Non-proliferative Diabetic Retinopathy","enrollment":480},{"nctId":"NCT01659580","phase":"PHASE3","title":"Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2012-08","conditions":"Angina Pectoris","enrollment":1004},{"nctId":"NCT01679028","phase":"PHASE1","title":"Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2012-08","conditions":"Healthy","enrollment":20},{"nctId":"NCT01825759","phase":"PHASE4","title":"Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2013-01","conditions":"Coronary Heart Disease, Essential Hypertension","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":80,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dantonic®"],"phase":"marketed","status":"active","brandName":"Compound danshen dripping pills","genericName":"Compound danshen dripping pills","companyName":"Tasly Pharmaceuticals, Inc.","companyId":"tasly-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Compound danshen dripping pills improve blood circulation and reduce blood stasis by promoting vasodilation and inhibiting platelet aggregation. Used for Angina pectoris, Myocardial infarction prevention, Coronary artery disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}